Search clinical trials for: Ciprofloxacin (Cipro, BAYQ3939)

Total 322 results

Bayer

Completed

Efficacy and Safety of CIPRO XR Versus CIPRO IR in Patients With Complicated Urinary Tract Infections (EMERON)

Urinary Tract Infection

Italy
Bayer

Completed

Ciprofloxacin Special Drug Use Investigation - To Investigate the Safety and Efficacy in Patients With Ciprofloxacin iv Administration Without Dilution

Infection

Japan
Bayer
Novartis

Completed

Study to Evaluate the Safety and Efficacy of Ciprofloxacin (Inhaled) in Patients With Cystic Fibrosis

Cystic Fibrosis

United States, Israel, Germany, Canada, Australia, Sweden, Denmark, Norway, United Kingdom
Bayer

Completed

Study in COPD (Chronic Obstructive Pulmonary Disease) Subjects to Investigate Safety, Tolerability, and Pharmacokinetics of Ciprofloxacin After Single Dose Inhalations of 50 mg and 75 mg Ciprofloxacin Inhalation Powder

Pulmonary Disease, Chronic Obstructive | Infection

Germany
Bayer

Completed

To Evaluate the Safety, Tolerability, Pulmonary Deposition, Pharmacokinetics and Pharmacodynamics of Ciprofloxacin Inhale in Japanese Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD, GOLD II-III)

Pulmonary Disease, Chronic Obstructive

Japan
Bayer

Completed

Study To Evaluate The Efficacy And Safety Of Ciprofloxacin Extended-Release (Cipro® XR) 1000 mg Tablets Given Once Daily For 7 To 14 Days In The Treatment Of Patients 18 Years Or Older With Complicated Urinary Tract Infections Caused By Pseudomonas Aeruginosa And Other Common Uropathogens

Urinary Tract Infections

United States
Bayer
Novartis

Completed

Evaluation of Cipro Inhale in Patients With Non-cystic Fibrosis Bronchiectasis

Bronchiectasis

Spain, Germany, Australia, United States, United Kingdom, Sweden
Bayer

Completed

Special Drug Use Investigation of Ciproxan Injection in Pediatrics

Cystitis / Pyelonephritis / Cystic Fibrosis / Anthrax

Japan
Bayer

Completed

Cipro Inhaler for Cystic Fibrosis Children Ages 6-12

Pseudomonas Infection

United States
Bayer

Completed

A Phase III Study to Evaluate the Safety, Efficacy and Pharmacokinetics/Pharmacodynamics of BAYQ3939 in Patients With Bacterial Pneumonia

Pneumonia

Japan
Bayer

Completed

A Phase IV Study of Cipro XR in Uncomplicated UTI (EXPRESS)

Urinary Tract Infections
Bayer

Completed

Study to Characterize Lung Deposition, Pharmacokinetics, Safety and Tolerability of Single Inhalations of Radiolabeled Ciprofloxacin Dry Powder in Healthy Subjects and Patients With Chronic Lung Diseases

Respiratory System

Germany
Bayer

Completed

Cipro® XR in Therapeutic Response and Activity (eXtRa) - Assessing Symptom Relief in Urinary Tract Infections

Urinary Tract Infection

United States
Bayer
Novartis

Completed

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Disease, Pulmonary

Germany
Otic Pharma

Completed

Safety and Efficacy Study of Foam Otic Cipro Compared to a Standard Solution ( Ciloxan - Alcon Labs ) to Treat Acute Otitis Externa

Otorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | Otitis

Israel
Otic Pharma

Completed

Safety and Efficacy of Once-Daily Dosing of FoamOtic Cipro Compared to Twice-Daily Dosing of Ciloxan Ear Drops in Patients With Acute External Otitis (Once-a-day)

Otorhinolaryngologic Diseases | Ear Diseases | Otitis Externa | Otitis

Israel
Bayer
Novartis

Completed

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Bronchiectasis | Pulmonary Disease, Chronic Obstructive

United States
University of Florida

Terminated

Clinical Trial of Oral Ciprofloxacin and Etoposide in Subjects With Resistant Acute Myeloid Leukemia (AML)(UF-AML-CE-101)

Acute Myeloid Leukemia | Leukemia | Acute Myelogenous Leukemia

United States
Bayer

Completed

Assessment of the Safety and Efficacy of Ciproxan-I.V. in Daily Clinical Practice - Analysis Results From a Post-marketing Surveillance

Infection

Japan
Bayer
Novartis

Completed

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) (RESPIRE 1)

Bronchiectasis

Spain, United States, New Zealand, Japan, France, Australia, Germany, Denmark, Israel, United Kingdom, Latvia, Italy, Slovakia, Argentina
Kaiser Permanente

Completed

A Pilot Study on the Use of Prophylactic Antibiotics for EUS-guided Pancreatic Cyst Aspiration

Pancreatic Cysts

United States
Bayer
Novartis

Completed

Ciprofloxacin Dry Powder for Inhalation (DPI) in Non-cystic Fibrosis Bronchiectasis (Non-CF BE) (RESPIRE 2)

Bronchiectasis

China, Hong Kong, Germany, Philippines, Russian Federation, United States, Australia, Austria, Czechia, Taiwan, Brazil, Korea, Republic of, Netherlands, Thailand, Latvia, Romania, Turkey, Serbia, Portugal, Bulgaria, Slovakia, Poland, Argenti... and more
Mount Sinai Hospital, Canada
Crohn's and Colitis Foundation

Terminated

Study of Antibiotics in the Treatment of Colonic Crohn's Disease

Crohn's Disease

Canada
Bayer
Novartis Pharmaceuticals

Completed

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany
Foundation for Liver Research

Completed

Adalimumab in Combination With Ciprofloxacin/Placebo Treatment of Perianal Fistulas in Crohn's (Adafi)

Crohn's Disease With Perianal Fistulas

Netherlands
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Mylan Pharmaceuticals Inc

Completed

Food Study of Ciprofloxacin Extended-Release Tablets 1000 mg and Cipro® XR Tablets 1000 mg

Healthy

United States
Farmoquimica S.A.
Pharmagenix Projetos em Medicina Farmacêutica Ltda.

Completed

A Comparative Study Between Two Formulations of the Ciprofloxacin Hydrochloride + Hydrocortisone Otic Suspension

Otitis Externa

Brazil
Mylan Pharmaceuticals Inc

Completed

Fasting Study of Ciprofloxacin Extended-Release Tablets 500 mg and Cipro® XR Tablets 500 mg

Healthy

United States
Wake Forest University Health Sciences
National Cancer Institute (NCI)

Withdrawn

Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy

Prostate Cancer

United States
Seattle Children's Hospital
National Heart, Lung, and Blood Institute (NHLBI); Cystic Fibrosis Foundation; CF Therapeutics Development Network Coordinating Center

Completed

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis (EPIC)

Pulmonary Disease, Chronic Obstructive | Cystic Fibrosis

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Non-Fasting Conditions

Fed

United States
Epicentre
Medecins Sans Frontieres, Netherlands

Withdrawn

Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

Meningitis, Meningococcal

Niger
University of Chicago

Terminated

Randomized Trial of Ciprofloxacin Versus Observation for Men With Elevated Prostate Specific Antigen (PSA)

Elevated Prostate Specific Antigen

United States
Ottawa Hospital Research Institute

Completed

REaCT Integrated Consent Model to Compare Two Standard of Care Regimens (OTT14-03)

Breast Cancer

Canada
Ain Shams University

Completed

Rifaximin as a Prophylaxis of Spontaneous Bacterial Peritonitis in Comparison With Ciprofloxacin

Spontaneous Bacterial Peritonitis

Egypt
Clinical Urology and Epidemiology Working Group
Helsinki University Central Hospital; Centre de recherche du Centre hospitalier... and other collaborators

Recruiting

Antibiotic Prophylaxis Before Shock Wave Lithotripsy (APPEAL)

Nephrolithiasis | Ureteral Calculi | Ureteral Stones

Finland, Brazil, Canada, Indonesia, Iran, Islamic Republic of, Ireland, Russian Federation, Saudi Arabia, Switzerland
Epicentre
Medecins Sans Frontieres, Netherlands

Completed

Ciprofloxacin for the Prevention of Meningococcal Meningitis

Meningitis, Meningococcal

Niger
Iterum Therapeutics, International Limited

Completed

Efficacy of Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infection (uUTI)

Antibiotic Resistant Infection | UTI - Lower Urinary Tract Infection

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Fasting

United States
University of Rochester

Terminated

Antibiotic Prophylaxis for Urinary Catheter Removal After Radical Prostatectomy (Abx)

Urinary Tract Infection | Prostate Cancer | Clostridium Difficile

United States
University of North Carolina, Chapel Hill
National Institute of Dental and Craniofacial Research (NIDCR)

Completed

BK Virus in Salivary Gland Disease: Treating the Potential Etiologic Agent

HIV | Salivary Gland Disease | Benign Lymphoepithelial Lesion

United States
The Methodist Hospital Research Institute

Completed

Ciprofloxacin for Prevention of BK Infection

BK Virus Infection

United States
University of Chicago

Withdrawn

Serial Endoscopic Surveillance & Direct Topical Antibiotics to Define the Role of Microbes in Anastomotic Healing (SES-DTA)

Rectal Cancer | Anastomotic Leak
University of Campinas, Brazil

Recruiting

Safety and Efficacy of Topical Moxifloxacin for Prevention of Post-Traumatic Endophthalmitis: Randomized Controlled Clinical Trial

Endophthalmitis | Moxifloxacin | Open Globe Injury | Post-Traumatic Endophthalmitis

Brazil
CR-CSSS Champlain-Charles-Le Moyne

Suspended

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer (BRP30)

Prostate Cancer

Canada
Southwest Oncology Group
National Cancer Institute (NCI)

Terminated

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Bladder Cancer

United States
Poitiers University Hospital

Terminated

Short or Long Schemes of Antibiotic Prophylaxis for Prostate Biopsy

Men Who Must Undergo a Prostate Biopsy Related to Prostate Cancer Suspicion.

France
UConn Health
Dialysis Clinic, Inc.; Nipro Medical Corporation

Completed

Potential Effect of Dialyzer Leaching of BPA From the Fresenius Optiflux 160NR Compared to the Nipro ELISIO-15H (bisphenol-A)

End Stage Renal Disease
Iterum Therapeutics, International Limited

Completed

Oral Sulopenem-etzadroxil/Probenecid Versus Ciprofloxacin for Uncomplicated Urinary Tract Infection in Adult Women

Uncomplicated Urinary Tract Infections

United States

3

Subscribe